Search Results - vadivel+ganapathy

3 Results

Sort By:

Prodrugs of Short-Chain Fatty Acids for Treatment of Intestinal Disorders and Colon Cancer

Current State of the Art: Colon cancer, IBS, Crohn’s disease and colitis present as some of the most difficult diseases to treat with the medications available currently. Treatment can be as drastic as surgery, chemotherapy, medications, such as cortisone, which can have sometimes serious and debilitating side effects. Colon cancer is treated with...

Published: 4/28/2020 | Inventor(s): Vadivel Ganapathy, Puttur Prasad, Robert Martindale

Keywords(s): Colon Cancer, Inflammatory Bowel Disease, Ulcerative Colitis

Category(s): Therapeutics

ATB0,+ as a Drug Target for the Treatment of Cancer

The current state of the artCancer is a complex disease and is the result of many dysfunctional molecular events. By identifying the abnormal gene and proteins that are responsible for cancer growth and progress, target therapies are developed to treat cancer. The problem with the current artAlthough the current targeted therapies have improved survival...

Published: 2/3/2020 | Inventor(s): Vadivel Ganapathy, Puttur Prasad

Keywords(s):

Category(s): Therapeutics

HM74A/HM74 Ligands as Anti-Cancer and Anti-Diarrheal Drugs

Tech ID: 2007-030: Compositions Comprising a GPR109 Ligand for Treating Disorders of the Digestive Tract and/or CancerState of the Art: Top drugs for colon cancer include Xeloda (Genetech), Erbitux (Johnson and Johnson), Eloxatin (Sanofi), and Gleevec (Novartis). These four drugs ranked in the top 10 selling cancer drugs of 2011 and totaled ~$4 billion...

Published: 10/5/2020 | Inventor(s): Vadivel Ganapathy, Puttur Prasad, Muthusamy Thangaraju, Gail Cresci

Keywords(s): Colon Cancer, Gene, Ligand

Category(s): Therapeutics